Immunological reactivity and bioactivity of tumour necrosis factor
- PMID: 2895848
- DOI: 10.1016/s0140-6736(88)91735-7
Immunological reactivity and bioactivity of tumour necrosis factor
Similar articles
-
Recombinant guinea pig tumor necrosis factor alpha stimulates the expression of interleukin-12 and the inhibition of Mycobacterium tuberculosis growth in macrophages.Infect Immun. 2005 Mar;73(3):1367-76. doi: 10.1128/IAI.73.3.1367-1376.2005. Infect Immun. 2005. PMID: 15731034 Free PMC article.
-
Characterisation of monoclonal antibodies to the TNF and TNF receptor families.Cell Immunol. 2005 Jul-Aug;236(1-2):78-85. doi: 10.1016/j.cellimm.2005.08.010. Epub 2005 Sep 12. Cell Immunol. 2005. PMID: 16157320
-
Liposome-associated tumor necrosis factor retains bioactivity in the presence of neutralizing anti-tumor necrosis factor antibodies.J Immunol. 1989 Aug 15;143(4):1192-7. J Immunol. 1989. PMID: 2787358
-
Tumour necrosis factor-alpha: the role of this multifunctional cytokine in asthma.Immunol Cell Biol. 2001 Apr;79(2):132-40. doi: 10.1046/j.1440-1711.2001.00980.x. Immunol Cell Biol. 2001. PMID: 11264706 Review.
-
[Tumor necrosis factor in the immunology of reproduction].Akush Ginekol (Mosk). 1993;(4):9-15. Akush Ginekol (Mosk). 1993. PMID: 8250127 Review. Russian. No abstract available.
Cited by
-
Tumour necrosis factor: a cytokine with multiple biological activities.Br J Cancer. 1990 Mar;61(3):354-61. doi: 10.1038/bjc.1990.78. Br J Cancer. 1990. PMID: 2183871 Free PMC article. Review. No abstract available.
-
Tumour necrosis factor production in Falciparum malaria and its association with schizont rupture.Clin Exp Immunol. 1989 Sep;77(3):361-6. Clin Exp Immunol. 1989. PMID: 2680183 Free PMC article.
-
Increased concentrations of tumour necrosis factor (TNF) and soluble TNF receptors in biliary obstruction in mice; soluble TNF receptors as prognostic factors for mortality.Gut. 1996 Mar;38(3):447-53. doi: 10.1136/gut.38.3.447. Gut. 1996. PMID: 8675101 Free PMC article.
-
Production of tumor necrosis factor alpha and interferon gamma in interleukin-2-treated melanoma patients: correlation with clinical toxicity.Cancer Immunol Immunother. 1991;34(1):49-52. doi: 10.1007/BF01741324. Cancer Immunol Immunother. 1991. PMID: 1760811 Free PMC article. Clinical Trial.
-
Lymphocyte activation and serine-esterase induction following recombinant interleukin-2 infusion for lymphomas and acute leukaemias.Cancer Immunol Immunother. 1991;33(2):133-7. doi: 10.1007/BF01742542. Cancer Immunol Immunother. 1991. PMID: 2036661 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources